TREA

78313401 - TARGET HEALTH

Follow

Information

  • Trademark
  • 78313401
  • Serial Number
    78313401
  • Registration Number
    3156025
  • Filing Date
    October 14, 2003
    21 years ago
  • Registration Date
    October 17, 2006
    18 years ago
  • Transaction Date
    August 13, 2020
    4 years ago
  • Status Date
    January 14, 2017
    8 years ago
  • Published for Opposition Date
    July 25, 2006
    18 years ago
  • Renewal Date
    October 17, 2016
    8 years ago
  • Location Date
    January 14, 2017
    8 years ago
  • First Use Anywhere Date
    January 01, 1993
    32 years ago
  • First Use In Commerce Date
    January 01, 1993
    32 years ago
  • Status Code
    800
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    KAZAZIAN, MICHAEL H
  • Attorney Docket Number
    3107.00013
    Attorney Name
    Kenneth I. Kohn
    Law Office Assigned Location Code
    M40
  • Owners
Information
Mark Drawing Code
1000
Mark Identification
TARGET HEALTH
Case File Statements
  • D10000: "HEALTH"
  • GS0351: Business auditing services, namely, performing pre-inspection goods manufacturing practices audits and assuring that user fee monies are submitted; biostatistics and data processing services; providing statistical information; performing statistical analyses; manufacturer representatives in the field of pharmaceuticals
  • GS0411: Computer services, namely, providing online journals in fields of health and medicine
  • GS0421: Providing quality assurance services in the field of pharmaceuticals; reviewing standards and practices to assure compliance with medical and pharmaceutical laws and regulations; reviewing standards and practices to assure compliance with US Food and Drug Administration (FDA) laws and regulations; consulting services regarding food and drug law and regulation compliance, namely, preparing for and conducting meetings to discuss and negotiate development strategies, preparing and submitting documents and forms required by the FDA, preparing responses to FDA questions and warning letters, follow-up with FDA on post application submission questions, preparing for and conducting meetings with legal counsel, troubleshooting product and process issues, performing analytical methods development and validation, and designing and implementing safety and regulatory toxicology programs; intellectual property licensing in the fields of drug, drug product, pharmaceutical and pharmaceutical products; medical and scientific research, namely, conducting clinical trials, specifically preparing protocols, case report forms and informed consent forms, performing qualification, initiation, monitoring and closeout visits, generating investigator study files, monitor drug supply, identifying study sites and managing investigator payments, and preparing clinical sites for FDA inspection; consultation in the fields of drug development, including working with sponsor, medical, scientific, toxicology, manufacturing and business experts to clearly delineate development requirements, evaluating available and competitive technologies; product and process development services; technical writing for others, specifically, integrated clinical and statistical study reports and other regulatory manuscripts
  • GS0441: Providing an on-line database for use in gathering and providing patient records and patient data via a global computer network
Case File Event Statements
  • 8/12/2020 - 4 years ago
    27 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 1/14/2017 - 8 years ago
    26 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Type: NA89
  • 1/14/2017 - 8 years ago
    25 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Type: RNL1
  • 1/14/2017 - 8 years ago
    24 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Type: 89AG
  • 1/12/2017 - 8 years ago
    23 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP
  • 8/3/2016 - 8 years ago
    22 - POST REGISTRATION ACTION MAILED - SEC. 8 & 9 Type: PR89
  • 8/1/2016 - 8 years ago
    21 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 5/11/2016 - 9 years ago
    20 - TEAS SECTION 8 & 9 RECEIVED Type: E89R
  • 9/12/2012 - 12 years ago
    19 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED Type: NA85
  • 9/12/2012 - 12 years ago
    18 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A
  • 9/12/2012 - 12 years ago
    17 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 8/20/2012 - 12 years ago
    16 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 10/17/2006 - 18 years ago
    15 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/25/2006 - 18 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/5/2006 - 18 years ago
    13 - NOTICE OF PUBLICATION Type: NPUB
  • 6/6/2006 - 19 years ago
    12 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 5/31/2006 - 19 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 5/15/2006 - 19 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/15/2005 - 19 years ago
    9 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 5/12/2005 - 20 years ago
    8 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 11/8/2004 - 20 years ago
    7 - LETTER OF SUSPENSION MAILED Type: CNSL
  • 11/8/2004 - 20 years ago
    6 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 11/5/2004 - 20 years ago
    5 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 10/20/2004 - 20 years ago
    4 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/20/2004 - 20 years ago
    3 - PAPER RECEIVED Type: MAIL
  • 5/11/2004 - 21 years ago
    2 - NON-FINAL ACTION MAILED Type: CNRT
  • 4/26/2004 - 21 years ago
    1 - ASSIGNED TO EXAMINER Type: DOCK